The Lundquist Institute

Torrance, California 90502

3 studies enrolling now · 8 studies all time

What they study most

ASCVD, ASCVD Management, Atherosclerosis Cardiovascular Disease, Cardiopulmonary, Diabetes Mellitus, Type 1, Healthy Lifestyle, Heart Failure With Preserved Ejection Fraction (HFpEF), Hypoparathyroidism, Men, Obese, Obesity, Pulmonary Embolism

Studies at this site

• Pulmonary Embolism - Thrombus Removal With Catheter-Directed Therapy — Recruiting now
• Efficacy, Safety, and PopPK Profile of ABP-745 in Patients With Atherosclerosis — Recruiting now
• Observational, Non-Interventional Study Supporting Validation of VO2Max Estimation Methods Using Results in Patients Receiving Standard of Care Cardiopulmonary Exercise Tests (CPET) — Recruiting now
• Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes — Running, not enrolling
• Project 1: Diet and Exercise Modulate the Sperm Epigenome in Men — Running, not enrolling
• A Study of Tirzepatide (LY3298176) in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF) and Obesity: The SUMMIT Trial — Completed
• Tavo and Pembrolizumab With or Without Chemotherapy in Patients With Inoperable Locally Advanced or Metastatic TNBC — Status unconfirmed
• A Clinical Study Investigating the Safety, Tolerability, PK and PD of PCO371 in Patients With Hypoparathyroidism — Stopped early